Predicting invasion in patients with DCIS in the preoperative percutaneous biopsy

Acta Oncologica

Volumn 46, Issue 6, 2007, Pages 798-802

  Leikola, Junnu ^a   Heikkilä, Päivi ^a   Pamilo, Martti ^a   Salmenkivi, Kaisa ^a   Von Smitten, Karl ^a   Leidenius, Marjut ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER INVASION; CANCER PATIENT; CANCER SCREENING; CANCER SURGERY; CONTROLLED STUDY; DUCTAL CARCINOMA IN SITU; ECHOMAMMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NEEDLE BIOPSY; PERCUTANEOUS BIOPSY; PREDICTION; PREOPERATIVE EVALUATION; PREVALENCE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; ULTRASOUND;

BIOPSY; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DISEASE PROGRESSION; FEMALE; HUMANS; MIDDLE AGED; PILOT PROJECTS; PREOPERATIVE CARE; PREVALENCE; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 34547154285     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860601128941     Document Type: Article

References (17)

1. Silverstein MJ. Ductal carcinoma in situ of the breast. Annu Rev Med 2000;51:17-32.
2. Cody HS,3rd, Klauber-Demore N, Borgen PI, Van Zee KJ. Is it really duct carcinoma in situ? Ann Surg Oncol 2001;8:617-9.
3. Mittendorf ME, Arciero CA, Gutchell V, Hooke J, Shriver CD. Core biopsy diagnosis of ductal carcinoma in situ: An indication for sentinel lymph node biopsy. Curr Surg 2005:62:253-7.
4. Cox CE, Dupont E, Whitehead GF, Ebert MD, Nguyen K, Peltz ES, et al. Age and body mass index may increase the chance of failure in sentinel lymph node biopsy for women with breast cancer. Breast J 2002;8:88-91.
5. Lee CH, Carter D, Philpotts LE, Couce ME, Horvath LJ, Lange RC, et al. Ductal carcinoma in situ diagnosed with stereotactic core needle biopsy: Can invasion be predicted? Radiology 2000;217:466-70.
6. Cox CE, Nguyen K, Gray RJ, Salud C, Ku NN, Dupont E, et al. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): Why map DCIS? Am Surg 2001;67:513-9; Discussion 519-21.
7. Klauber-DeMore N, Tan LK, Liberman L, Kaptain S, Fey J, Borgen P, et al. Sentinel lymph node biopsy: Is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion? Ann Surg Oncol 2000;7:636-42.
8. Leidenius M, Salmenkivi K, von Smitten K, Heikkila P. Tumour positive sentinel node findings in patients with ductal carcinoma in situ. J Surg Oncol 2006;94:380-4.
9. Pendas S, Dauway E, Giuliano R, Ku N, Cox CE, Reintgen DS. Sentinel node biopsy in ductal carcinoma in situ patients. Ann Surg Oncol 2000;7:15-20.
10. Yen TW, Hunt KK, Ross MI, Mirza NQ, Babiera GV, Meric-Bernstam F, et al. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: A guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg 2005;200:516-26.
11. Leidenius M, Krogerus L, Toivonen T, Leppanen E, von Smitten K. The sensitivity of axillary staging when using sentinel node biopsy in breast cancer. Eur J Surg Oncol 2003;29:849-53.
12. Silverstein MJ, Poller DN, Waisman JR, Colburn WJ, Barth A, Gierson ED, et al. Prognostic classification of breast ductal carcinoma-in-situ. Lancet 1995;345(8958):1154-7.
13. Consensus Conference on the classification of ductal carcinoma in situ. The Consensus Conference Committee. Cancer 1997;80:1798-802.
14. American Joint Committee on Cancer. Cancer Staging Manual. 6th ed. New York: Springer-Verlag; 2002.
15. Moon WK, Myung JS, Lee YJ, Park IA, Noh DY, Im JG. US of ductal carcinoma in situ. Radiographics 2002;22:269-80; Discussion 280-1.
16. Yang WT, Tse GM. Sonographic, mammographic, and histopathologic correlation of symptomatic ductal carcinoma in situ. AJR Am J Roentgenol 2004;182:101-10.
17. Renshaw AA. Predicting invasion in the excision specimen from breast core needle biopsy specimens with only ductal carcinoma in situ. Arch Pathol Lab Med 2002;126:39-41.